AVADEL PHARMACEUTICALS - COM (AVDL)
Historical Holders from Q4 2016 to Q3 2025
-
Type / Class
-
Equity / COM
-
Symbol
-
AVDL on Nasdaq
-
Price per share
-
$15.27
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
737,501
-
Total reported value
-
$11,261,641
-
Share change
-
0
-
Number of holders
-
3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025,
AVADEL PHARMACEUTICALS - COM (AVDL) has
3
institutional shareholders
filing 13F forms.
They hold
737,501 shares.
.
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
737,501
|
$11,261,641
|
|
|
$0
|
$15.27
|
3
|
|
2025 Q2
|
737,501
|
$6,526,891
|
|
|
$215,475
|
$8.85
|
3
|
|
2025 Q1
|
737,501
|
$5,774,641
|
+$3,915
|
|
|
$7.83
|
3
|
|
2024 Q4
|
737,001
|
$7,745,886
|
-$4,367,129
|
|
|
$10.51
|
3
|
|
2024 Q3
|
1,070,001
|
$14,032,886
|
-$83,726,146
|
|
|
$13.12
|
5
|
|
2024 Q2
|
7,025,014
|
$98,771,327
|
-$1,036,586,640
|
$0
|
$0
|
$14.06
|
10
|
|
2024 Q1
|
67,722,533
|
$1,143,897,781
|
+$208,583,662
|
$34,279,944
|
$16,825,818
|
$16.89
|
121
|
|
2023 Q4
|
19,912
|
$281,157
|
-$475,265
|
|
|
$14.12
|
1
|
|
2023 Q3
|
53,840,366
|
$554,583,076
|
-$2,768,794
|
$3,010,690
|
$7,887,740
|
$10.30
|
95
|
|
2023 Q2
|
51,492,222
|
$848,604,177
|
+$73,277,101
|
$10,166,376
|
$11,691,712
|
$16.48
|
98
|
|
2023 Q1
|
48,371,490
|
$443,036,185
|
+$137,994,249
|
$4,475,576
|
$13,762,824
|
$9.16
|
88
|
|
2022 Q4
|
33,455,552
|
$239,492,674
|
+$16,217,340
|
$8,356,116
|
$10,391,328
|
$7.16
|
83
|
|
2022 Q3
|
31,382,376
|
$157,239,505
|
-$10,630,387
|
$6,324,000
|
$3,971,000
|
$5.01
|
72
|
|
2022 Q2
|
33,734,094
|
$82,308,348
|
-$28,507,344
|
$2,235,000
|
$2,578,000
|
$2.44
|
75
|
|
2022 Q1
|
35,805,427
|
$244,542,225
|
+$7,001,576
|
$2,281,000
|
$4,883,000
|
$6.83
|
76
|
|
2021 Q4
|
34,864,629
|
$281,718,295
|
+$3,984,190
|
$3,562,552
|
$5,910,000
|
$8.08
|
78
|
|
2021 Q3
|
32,066,701
|
$314,225,653
|
-$2,632,863
|
$1,584,800
|
$14,101,680
|
$9.80
|
81
|
|
2021 Q2
|
32,552,132
|
$219,088,519
|
-$1,445,645
|
$1,585,730
|
$2,990,033
|
$6.73
|
79
|
|
2021 Q1
|
32,624,275
|
$294,399,454
|
+$1,571,170
|
$2,641,000
|
$2,590,000
|
$9.04
|
77
|
|
2020 Q4
|
32,022,122
|
$213,943,593
|
+$3,570,784
|
$1,058,000
|
$846,000
|
$6.68
|
78
|
|
2020 Q3
|
31,489,502
|
$158,737,854
|
-$40,676,724
|
$812,000
|
$1,035,000
|
$5.04
|
76
|
|
2020 Q2
|
36,267,155
|
$293,030,910
|
+$72,708,094
|
$2,990,000
|
$3,432,000
|
$8.08
|
72
|
|
2020 Q1
|
26,839,702
|
$211,145,000
|
+$56,683,867
|
$2,829,000
|
$23,455,000
|
$7.94
|
53
|
|
2019 Q4
|
18,244,413
|
$137,742,000
|
+$2,567,714
|
$1,376,000
|
$1,476,000
|
$7.55
|
42
|
|
2019 Q3
|
19,368,854
|
$80,575,000
|
+$347,478
|
$239,000
|
$308,000
|
$4.16
|
39
|
|
2019 Q2
|
19,319,440
|
$55,832,000
|
-$530,738
|
$92,000
|
|
$2.89
|
39
|
|
2019 Q1
|
19,575,523
|
$28,191,000
|
-$905,815
|
$0
|
|
$1.44
|
36
|
|
2018 Q4
|
19,744,561
|
$50,896,000
|
-$1,392,366
|
$54,000
|
$0
|
$2.58
|
46
|
|
2018 Q3
|
20,130,519
|
$88,363,000
|
-$2,836,965
|
$270,000
|
$160,000
|
$4.39
|
60
|
|
2018 Q2
|
20,572,581
|
$126,110,065
|
-$36,190,040
|
$553,000
|
$364,000
|
$6.13
|
66
|
|
2018 Q1
|
25,861,666
|
$188,525,000
|
-$4,818,388
|
$831,000
|
$597,000
|
$7.29
|
71
|
|
2017 Q4
|
25,787,593
|
$211,448,000
|
-$16,854,007
|
$388,000
|
|
$8.20
|
73
|
|
2017 Q3
|
27,149,143
|
$284,285,000
|
-$5,516,082
|
$279,000
|
|
$10.50
|
77
|
|
2017 Q2
|
26,131,042
|
$288,224,000
|
+$21,561,742
|
|
$0
|
$11.03
|
72
|
|
2017 Q1
|
26,582,727
|
$257,486,000
|
+$215,656,341
|
|
$131,000
|
$9.68
|
67
|
|
2016 Q4
|
4,300,449
|
$44,678,000
|
+$44,677,983
|
|
|
$10.39
|
6
|